PMHS · Polomar Health Services, Inc.
$0.30
At close · Aug 26
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the financial statements are issued and determined that substantial doubt exists about the Company's ability to continue as a going concern. The Company's ability to continue as a going concern is dependent on the Company's ability to generate revenues and raise capital. The Company has not generated sufficient income and has historically depended on notes or equity to fund operations. As of June 30, 2026, the Company has an accumulated deficit of $13,526,169. These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the date of filing of the 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.51M
Shares
28.38M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$648.23K
+1002%
FY2025
Net Income
-$10.7M
-697.8%
FY2025
Gross Margin
70.98%
+18.4pp
FY2025
Operating Margin
-1627.55%
+581.6pp
FY2025
Diluted EPS
-$0.39
-680%
FY2025
Operating Cash Flow
-$396K
+61.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| $3.17M | $648.23K | $58.82K | $41.84K | $34.53K | |
| $1.23M | $188.13K | $27.92K | $4294 | — | |
| $1.94M | $460.1K | $30.9K | $37.55K | $34.53K | |
| — | 70.98% | 52.53% | 89.74% | 100% | |
| $804.18K | $66.57K | $46K | $27.93K | — | |
| $10.5M | $10.94M | $1.28M | $450.45K | $215.98K | |
| $9.27M | $9.77M | $263.28K | $5833 | — | |
| $11.3M | $11.01M | $1.33M | $478.38K | $215.98K | |
| -$9.36M | -$10.55M | -$1.3M | -$440.83K | -$181.45K | |
| — | -1627.55% | -2209.13% | -1053.51% | -525.55% | |
| -$85.97K | -$776.94K | -$1.04M | -$435K | — | |
| $103.66K | $150.84K | $41.84K | $495 | — | |
| -$103.66K | -$150.84K | -$41.84K | -$147.17K | $329 | |
| -$9.46M | -$10.7M | -$1.34M | -$588K | -$181.12K | |
| — | -1650.82% | -2280.25% | -1405.21% | -524.6% | |
| USD/shares | -$0.35 | -$0.39 | -$0.05 | -$0.02 | $0.00 |
| USD/shares | -$0.35 | -$0.39 | -$0.05 | -$0.02 | $0.00 |
| shares | — | 27.76M | 27.66M | 26.11M | 45.25M |
| shares | — | 27.76M | 27.66M | 26.12M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—